$NOVO Bob Moriarty recent post on

New Post Public Reply Private Reply Replies (0) Message Board
Until2017
883
$NOVO Bob Moriarty recent post on Novo

http://www.321gold.com/editorials/moriarty/mo...22118.html

Novo is on Sale for a Little While
Bob Moriarty
Archives
Feb 21, 2018

Novo shares are going to be on the sales rack from now until March 8th with about 3 million warrants at $.85 expiring then. It's perfectly normal for warrant holders to sell shares in order to exercise the warrants. For the past three weeks about 300,000 to 400,000 shares per day have traded on average. Selling warrant holders don't need to sell one share for each warrant held since the share price is about four times higher than the exercise price but with the lower liquidity of Novo recently any selling will tend to depress prices artificially. That overhang disappears on the 8th of March.

Quinton Hennigh of Novo released more assay results and an update on Comet Well and Purdy's Reward on February 14th. It was pretty bland but it did have an important chart in it that answered a lot of questions for me.

A lot of experts and non-experts have visited Karratha and seen both Comet Well and Purdy's Reward. Reactions vary a lot. When I was there with Brent Cook in July the price had just started rocketing higher. Brent Cook got his readers in cheap and when prices got carried away in October and November was wise enough to get his people out at a nice profit. His latest comments indicated a concern with mining as an open pit and what the strip ratio might be.

John Kaiser came in acting as if he had been in the yardarms when Captain Cook first sighted Australia in 1770 and played an important part in the discovery. After his visit he recommended his readers buy the stock saying he believed it could be a 20 billion ounce deposit. Now given that the world has only produced maybe 6 billion ounces, he was getting a little carried away. He corrected that later in the year suggesting that he wasn't sure that Vits grade and Vits thickness at surface would be economic. Now given that they are mining almost 4 km deep in South Africa, home of the Vits, that comment by Kaiser was pretty shocking. Not quite as shocking as the 20 billion ounces comment but still right up there.

I think I got it. I have been a giant supporter of Novo and Quinton Hennigh for yonks. I have believed since my first visit in 2009 that Quinton's precipitation theory was valid and Western Australia had the potential for another Witwatersrand type deposit.

In an early piece this summer I predicted that the bulk of the gold would be at the lower portion of the conglomerate sequence. That turned out to be true. But the real question was, what kind of mining thickness would you have? Brent Cook had a perfectly valid concern about strip ratio but I have never believed this had a big open pit potential. The big potential is in the conglomerate under the basal cover. Novo has almost 10,000 square km of ground, much of it under cover and it will require underground mining hopefully using mechanized mining equipment.

With the latest results, Novo attached a number of pictures and one important chart. The chart shows a drawing of the lower conglomerate sequence at the dolerite contact. Novo has put in all of the assays to date so a reader can visually see where the gold is. I like it a lot.


( Strata graphic in original NOT POSTED here. )

Many moons ago I said that this was an unconventional deposit and had to be approached in an unconventional way. Virtually all of the gold to date consists of large nuggets. That creates a monster problem because of the nugget effect. The larger the gold, the harder it is to measure. While both Quinton and Brent Cook believe that somewhere there will be finer gold that is easier to measure I'm not so sure I care. Gold is gold, big or small. If you have a ton of large nuggets, which works for me and clearly Karratha has a lot of gold. Everyone agrees on that.

While the punters want to see that 40-50-60 g/t gold as I do, they are missing the potential of the 1-2 g/t material above and below the high-grade sequence. With $1350 or so gold today a gram is still worth about $43. With any mining, you have to consider mining width and dilution. If you have $40-$80 material for half a meter above and below $2000 material you have a mining sequence that works.

Novo has realized that with nuggety gold, you have to have large samples to determine a representative grade. The diamond core drilling was useless for grade; it only reflects structure of the conglomerates as I said it would. The large diameter drilling didn't work because the gold is too dense to blow out of the hole. The best way to measure the gold is simply to mine it. And while they can call the large bulk samples, it's really just small mining.

The company has arranged access with SGS in Perth to use their test plant to process 5 ton samples as compared to the 300 kg samples they have been testing. They believe the larger samples will more closely represent the real grade of the material. I agree.

With each press release, investors have more information to make an intelligent decision about determining if they should buy or sell. I love Novo and Quinton Hennigh and I firmly believe the company is on track. They have serious money in the bank and are under no particular financial pressure. Quinton has assembled a brilliant team in Western Australia and progress is being made daily.

I still own the shares that I paid for at $.25 in the first PP many moons ago. I wish I had been wise enough to sell a bunch and move the money into Kirkland Lake at the top in October/November. KLG is a similar bet on Karratha and the Pilbara Basin but less leveraged. In any case, Novo was cheap in July, expensive in November and back to cheap again. Any of the chat board commandos who have given up on the Novo story are going to get caught out at the airport when their ship comes in.

Novo is an advertiser. It is my largest share position and I couldn't possibly be any more biased than I am. It's a great story, still in progress and they do a good job of communicating the very real value in the company. You are responsible for your own due diligence.

Novo Resources
NVO-V $3.30 (Feb 20, 2018)
NSRPF $2.64 OTCQX 148 million shares
Novo Resources website

###

Bob Moriarty
President: 321gold
Archives



Until2017

Novo Resources Corp (NSRPF) Stock Research Links

NSRPF Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 15

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 19

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 24

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 19

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 20

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 19

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 18

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 21

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 14

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading

Top 5 Most Recently Viewed Articles

National Power Mobilizes Storm Response Teams for Hurricane

Updated Category News Views 119

National Power's Preparedness for Hurricane Milton As Hurricane Milton approaches, National Power has actively mobilized its dedicated teams to ensure mission-critical operations are not disrupted. With a strong focus on readiness, the company is prepared to deliver essential power and infrastructure support to vital services such as broadband and emergency facilities...

Continue Reading
Edible Garden Reports Significant Revenue Growth in CPG Sector

Updated Category News Views 138

Edible Garden Achieves 9% Revenue Growth Edible Garden AG Incorporated (NASDAQ: EDBL) has reported an encouraging 9% increase in revenue, marking a significant milestone for the company in the competitive consumer packaged goods (CPG) sector. The growth comes as Edible Garden diversifies its product offerings and expands its retail partnerships, positioning itself firmly...

Continue Reading
Sapiens International Announces Impressive Dividend Payouts

Updated Category News Views 304

Sapiens International Declares Substantial Cash Dividend Sapiens International Corporation N.V. (NASDAQ: SPNS), a distinguished leader in providing software solutions for the insurance industry, has unveiled a notable cash dividend distribution following their financial achievements. The board of directors has sanctioned a cash dividend of $0.30 per share, culminating in...

Continue Reading
Cybernet’s G22 Medical PC Revolutionizes Endoscopy at DDW 2025

Updated Category News Views 253

Cybernet’s Groundbreaking Medical Panel PC at DDW 2025 During the recent Digestive Disease Week (DDW) 2025 conference, the spotlight was on revolutionary advancements in endoscopic technology. A significant highlight was the display of the Cybermed G22, a state-of-the-art 22-inch medical panel PC. This cutting-edge device is integral to Fujifilm's next-generation...

Continue Reading
CVS Health's Strategic Moves Boost Medicare Margins and Market Share

Updated Category News Views 96

CVS Health's Strategic Upsurge in the Pharmacy Sector CVS Health Inc (NYSE: CVS) has recently come under the positive spotlight as Barclays improves its outlook on the company. The upgrade stems from more favorable predictions concerning Pharmacy & Consumer Wellness (PCW) estimates. Interestingly, despite facing macroeconomic challenges affecting the retail pharmacy...

Continue Reading